EyePoint, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
EyePoint, Inc. (EYPT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $2.99 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-03-05
- EyePoint, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $2.99M, a 88.28% increase from fiscal 2024.
- EyePoint, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $1.59M.
- EyePoint, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2022 was $1.03M, a 49.21% increase from fiscal 2021.
- EyePoint, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2021 was $693.00K, a 71.96% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|---|
| 2025-12-31 | $2.99M 10-K · filed 2026-03-05 | |
| 2024-12-31 | $1.59M 10-K · filed 2026-03-05 | |
| 2022-12-31 | $1.03M 10-K · filed 2023-03-10 | |
| 2021-12-31 | $693.00K 10-K · filed 2023-03-10 | |
| 2020-12-31 | $403.00K 10-K · filed 2022-03-14 | |
| 2019-12-31 | $150.00K 10-K · filed 2021-03-12 | |
| 2018-12-31 | $231.00K 10-K · filed 2020-03-16 | |
| 2018-06-30 | $284.00K 10-K · filed 2020-03-16 | |
| 2017-06-30 | $242.00K 10-K · filed 2020-03-16 | |
| 2016-06-30 | $397.00K 10-KT · filed 2019-03-18 | |
| 2015-06-30 | $313.00K 10-K · filed 2017-09-13 | |
| 2014-06-30 | $169.00K 10-K · filed 2016-09-13 | |
| 2013-06-30 | $134.00K 10-K · filed 2015-09-10 | |
| 2012-06-30 | $156.00K 10-K · filed 2014-09-11 | |
| 2011-06-30 | $106.00K 10-K · filed 2013-09-27 | |
| 2010-06-30 | $132.00K 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |